Showing results (571-580 of 2,811) with videos related to
Sort By:
Pageof 282
Expert Opinion on Drug Safety|June 18, 2014
Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosisMelanie D Ward, David E Jones, Myla D GoldmanExpert Opinion on Drug Safety|June 26, 2014
Safety overview of FDA-approved medications for the treatment of the motor symptoms of Parkinson's diseaseMichele A FaulknerExpert Opinion on Drug Safety|January 7, 2014
Pattern and associated factors of anti-hepatitis C virus treatment-induced adverse reactionsSaeedeh Ravi, Mohsen Nasiri-Toosi, Iman Karimzadeh, et al.Expert Opinion on Drug Safety|February 14, 2015
Therapy-related myelodysplastic syndromeMyrna Candelaria, Alfonso Dueñas-GonzalezExpert Opinion on Drug Safety|June 29, 2014
Drug safety evaluation of olanzapine/fluoxetine combinationMario A Cristancho, Michael E ThaseExpert Opinion on Drug Safety|February 14, 2015
Drug safety and tolerability in prophylactic migraine treatmentLászló Vécsei, Zsófia Majláth, Délia Szok, et al.Expert Opinion on Drug Safety|March 3, 2015
Tolerance of the newborn to antiretroviral drug exposure in uteroJeanne Sibiude, Josiane Warszawski, Stéphane BlancheExpert Opinion on Drug Safety|March 4, 2015
The use of insulin detemir during pregnancy: a safety evaluationRonit Koren, Yoel Toledano, Moshe HodExpert Opinion on Drug Safety|March 31, 2015
Safety of infliximab for the treatment of inflammatory bowel disease: current understanding of the potential for serious adverse eventsReena Khanna, Brian G FeaganExpert Opinion on Drug Safety|March 17, 2015
Drug safety evaluation of ulipristal acetate in the treatment of uterine fibroidsEmanuela Tafi, Carolina Scala, Umberto Leone Roberti Maggiore, et al.Pageof 282